DGAP-Adhoc

Carl Zeiss Meditec AG expects results to be burdened by participation in Oraya Therapeutics Inc.

Carl Zeiss Meditec AG / Key word(s): Miscellaneous

09.10.2015 12:29

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Jena, 9 October 2015: Carl Zeiss Meditec (ISIN: DE0005313704) expects its
financial result to be burdened by an impairment of the investment in Oraya
Therapeutics Inc. of around EUR 20 million.

Oraya Therapeutics Inc. markets a radiotherapy for wet, age-related macular
degeneration ("wet AMD") in the United Kingdom, Germany and Switzerland.
Carl Zeiss Meditec has provided funds used for further expansion of the
business of Oraya Therapeutics Inc. under an agreement concluded in
December 2014. Progress has been made in commercializing the therapy during
the year. However, there has been a significant deviation from the original
business plan, so that an adjustment of the book value of the investment is
necessary.

The annual report for business year 2014/15 will be published on 16
December 2015.

Contact for investors
Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG
Tel. [phone], E-Mail: [e-mail]

Press contact
Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss
Meditec AG
Tel. [phone], E-Mail: [e-mail]


09.10.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail],[e-mail]
Internet: www.meditec.zeiss.de
ISIN: DE0005313704
WKN: 531370
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------